 Including the contract transfers of the external studies planned for the successful out-licensing and commercialization of SAL200 BOSTON and SEOUL, South Korea, Jan. 11, 2023 PRNewswire iNtRON Biotechnology iNtRON, has announced today that the Tech Transfer process of SAL200, endolysin-based new biologic, is in the final stage. According to the Company official, the Tech ...... 